Basic Information
| LncRNA/CircRNA Name | SNHG12 |
| Synonyms | NA |
| Region | GRCh38_1:28578538-28582983 |
| Ensemble | ENSG00000197989 |
| Refseq | NR_024127 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | OC tissues,cell line (IOSE80,SKOV3, OVCAR3,A2780,HO8910) |
| Expression Pattern | up-regulated |
| Function Description | SNHG12 was upregulated in OCtissues relative to adjacent normal ones. |
| Pubmed ID | 30964158 |
| Year | 2019 |
| Title | LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4. |
External Links
| Links for SNHG12 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |